Bionano reports revenue growth as new CPT billing codes for genome tests take effect

Bionano Genomics reported first-quarter revenue growth and highlighted the activation of new CPT billing codes for its optical genome mapping tests. The company's financial results are directly tied to the recent implementation of these codes, which create a clearer reimbursement pathway for complex genetic analyses. This signals a successful code adoption for a niche diagnostic technology. Billing teams in genetics and oncology should verify that their systems are updated with the latest CPT codes for optical genome mapping to ensure clean claims for these services.